Envisagenics unlocks previously inaccessible cures for
hundreds of diseases caused by splicing errors
by integrating AI and RNA therapeutics.
Cancer and genetic diseases
affect more than 30 million people
Our mission is to reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions through RNA splicing analytics and artificial intelligence.
15%
of all disease causing mutations are predicted to disrupt RNA splicing
370
known genetic disorders in publications are caused by RNA splicing errors
50%
of synonymous cancer-driver mutations impair RNA splicing
Artificial Intelligence Platform for Drug Discovery
- Investors
- Partners
Sign up for the latest updates
Subscribe to the Envisagenics email newsletter
@envisagenics
© 2018 Envisagenics Inc. All rights reserved.